Attgeno

Attenua

This company develops small-molecule medicines for patients suffering from chronic respiratory disorders, particularly chronic cough.

VERO Biotech

This company develops tankless inhaled nitric oxide delivery systems for hospitals treating patients with pulmonary and cardiac conditions.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.

Activaero

The company develops controlled breathing systems and smart nebulisers to deliver inhaled drugs for patients with severe respiratory diseases.

Cereno Scientific

This biotech company develops epigenetic therapies for patients with rare cardiovascular and pulmonary diseases.

Atsena Therapeutics

This clinical-stage company develops gene therapies to treat and prevent inherited retinal diseases for patients with conditions such as X-linked retinoschisis and Stargardt disease.